Table 1 Demographic and clinical characteristics of the entire cohort
Demographics | |
Age at index date, years, median [IQR] | 77 [75, 82] |
Male gender, n (%) | 19,300 (44.1) |
Sectors | |
Non-Orthodox Jews, n (%) | 35,515 (81.2) |
Orthodox Jews, n (%) | 5,780 (13.2) |
Arabs, n (%) | 2,442 (5.6) |
Frailty | |
None, n (%) | 24,341 (55.7) |
Mild, n (%) | 12,260 (28.0) |
Moderate, n (%) | 5,533 (12.6) |
Severe, n (%) | 1,603 (3.7) |
Chronic diseases and age-related health deficits | |
Essential hypertension, n (%) | 36,205 (82.8) |
Arthritis, n (%) | 25,677 (58.7) |
Hearing impairment, n (%) | 17,514 (40.0) |
Coronary artery disease, n (%) | 13,385 (30.6) |
Type 2 diabetes mellitus, n (%) | 13,230 (30.2) |
Obstructive lung disease, n (%) | 12,132 (27.7) |
Peripheral vascular disease, n (%) | 12,093 (27.6) |
Anxiety, n (%) | 11,640 (26.6) |
Depression and mood disorders, n (%) | 10,980 (25.1) |
Chronic thyroid disease, n (%) | 9,408 (21.5) |
Active cancer, n (%) | 9,097 (20.8) |
Cerebrovascular disease, n (%) | 9,110 (20.8) |
Gastrointestinal disease, n (%) | 8,388 (19.2) |
Chronic kidney disease, n (%) | 6,793 (15.5) |
Atrial fibrillation or flutter, n (%) | 6,389 (14.6) |
Dementia, n (%) | 5,560 (12.7) |
Heart failure, n (%) | 5,280 (12.1) |
Anemia, n (%) | 4,887 (11.2) |
Parkinson’s disease, n (%) | 3,600 (8.2) |
Muscular wasting, n (%) | 3,462 (7.9) |
Gait abnormality, n (%) | 3,416 (7.8) |
Vision impairment, n (%) | 3,151 (7.2) |
Osteoporosis, n (%) | 2,670 (6.1) |
Fecal or urinary incontinence, n (%) | 2,428 (5.6) |
Peripheral neuropathy, n (%) | 1,983 (4.5) |
Recurrent falls, n (%) | 1,653 (3.8) |
Fatigue, n (%) | 1,362 (3.1) |
Weight loss in the previous year, n (%) | 1,240 (2.8) |